Also categorized in BoardNews:
Why Should We Care About Corporate Interlocks?
x hide permanently

Poison pill won't disrupt Allergan deal: Ackman

CNBC.com

Activist investor Bill Ackman told CNBC Tuesday that Allergan's adoption of a poison-pill defense does not necessarily make the takeover bid more difficult...

Mentions: Management Poison Pill Takeover Bid